HARVARD BIOSCIENCE INC — Director's Dealing 2020

May 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-05-07

Reporting Person: Green James W (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-07	Common Stock	P	10000	$2.53	Acquired	1512445	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $2.525 to $2.53, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Includes (a) deferred stock award of 35,100 restricted stock units which fully vest on May 23, 2020; (b) 202,875 restricted stock units that will fully vest on July 8, 2020; (c) 243,072 restricted stock units that will fully vest on July 8, 2021; (d) 313,770 restricted stock units that will vest in three equal installments on January 1, 2021, 2022 and 2023; (e) 418,360 restricted stock units with performance based vesting conditions tied to relative total shareholder return; and (f) 299,268 shares of common stock beneficially owned by the Reporting Person.